Taken together, our results prove the upregulation of inhibitory markers of CD4+CXCR5−FOXP3+ T cells in chronic HBV infection and HBV-related liver failure, further suggesting that they may be associated with dysregulated anti-HBV immune response. This evidence concerns the gene CD4 and Hepatic failure.